Baxter Phillips Iii

Biography

Mr. Phillips has 20 years of executive experience and a record of success in leading multinational corporate strategy efforts and structuring, negotiating, and executing financings, strategic alliances, licenses and collaborations in the biotechnology and pharmaceutical industry. Most recently, Mr. Phillips was the Chief Business Officer of AmpliPhi Biosciences (NYSE: APHB) where he played a pivotal role in establishing the Company’s ex-US manufacturing facility, led multiple financing campaigns and navigated the company to its recent NYSE listing. Prior to AmpliPhi, Mr. Phillips’ leadership appointments included Depomed (NASDAQ: DEPO), where he was responsible for licensing the company’s product portfolio of development-stage and marketed products on a global basis and Osteologix, where he successfully concluded a global licensing transaction with a multinational pharmaceutical company. Mr. Phillips began his career as a Research Scientist with Insmed, Inc. (NASDAQ: INSM) where for ten years he held a range of leadership positions in research, licensing, finance, investor relations, and sales and marketing. He earned his MBA from the College of William and Mary and his Bachelor of Science in Biology from Hampden-Sydney College. 

Research Interest

Venture-stage biopharmaceutical company, developing safe and effective products for the treatment of gastrointestinal disorders